Printer's No. PN3961
See other bills
under the
same topic PRINTER'S NO. 3961 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.643 Session of 2026 INTRODUCED BY STRUZZI, CIRESI, CONKLIN, FLEMING, GALLAGHER, MIHALEK, RIVERA, ROWE, SMITH, VENKAT AND WALLEN, SEPTEMBER 29, 2026 REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 29, 2026 A RESOLUTIONRecognizing the month of July 2026 as "Juvenile Arthritis Awareness Month" in Pennsylvania.WHEREAS, Juvenile arthritis is an umbrella term that refers to pediatric rheumatic diseases that can develop in children 16 years of age or younger; andWHEREAS, Juvenile idiopathic arthritis (JIA) is an autoinflammatory disease of an unknown origin and the most common type of arthritis in children; andWHEREAS, An autoinflammatory disease causes the immune system to become overactive even when there is no infection or illness to fight or mistakenly attack healthy cells and tissues; andWHEREAS, There is no evidence as to what causes JIA, and no links have been found that foods, toxins, allergies or the lack of vitamins play a role in developing the disease; andWHEREAS, Current research indicates that there is a genetic predisposition to JIA; andWHEREAS, Researchers believe that a trigger, such as a virus, 1234567891011121314151617 can initiate JIA in a child who has the genetic tendency; andWHEREAS, Systemic JIA, oligoarticular JIA, polyarticular JIA, juvenile psoriatic arthritis, enthesitis-related JIA and undifferentiated arthritis are the six subtypes of JIA; andWHEREAS, Nearly 300,000 children in the United States have some form of arthritis; andWHEREAS, Typical symptoms of arthritis include limping, stiffness when awakening, reluctance to use an arm or leg, reduced activity level, persistent fever, joint swelling and difficulty with fine motor skills; andWHEREAS, Most children with arthritis can expect to live normal lives and some even have their arthritis go into remission; andWHEREAS, There is a small number of specialists who treat JIA, and the Children's Hospital of Philadelphia is a leader in the field; andWHEREAS, According to the American College of Rheumatology, the best care for a child who has JIA is provided by a pediatric rheumatology team that has extensive experience and can diagnose and manage their complex needs; andWHEREAS, A pediatric rheumatology team may consist of a pediatric rheumatologist, a physical therapist, an occupational therapist, a social worker and a nurse specialist who coordinate care with other health professionals and school and community officials; andWHEREAS, The overall treatment goal for a child who has JIA is to control the symptoms, prevent joint damage and maintain function; andWHEREAS, Medications, including steroids, disease-modifying drugs and biologics along with physical and occupational therapy 20260HR0643PN3961 - 2 - 123456789101112131415161718192021222324252627282930 are used to treat JIA; andWHEREAS, Parents and caregivers of children who have JIA should be familiar with 29 U.S.C. Ch. 16 (relating to vocational rehabilitation and other rehabilitation services), which may provide for special accommodations at school; andWHEREAS, Children who have JIA may be eligible for assistance through services provided by State agencies; therefore be itRESOLVED, That the House of Representatives recognize the month of July 2026 as "Juvenile Arthritis Awareness Month" in Pennsylvania.20260HR0643PN3961 - 3 - 12345678910
under the
same topic PRINTER'S NO. 3961 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.643 Session of 2026 INTRODUCED BY STRUZZI, CIRESI, CONKLIN, FLEMING, GALLAGHER, MIHALEK, RIVERA, ROWE, SMITH, VENKAT AND WALLEN, SEPTEMBER 29, 2026 REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 29, 2026 A RESOLUTIONRecognizing the month of July 2026 as "Juvenile Arthritis Awareness Month" in Pennsylvania.WHEREAS, Juvenile arthritis is an umbrella term that refers to pediatric rheumatic diseases that can develop in children 16 years of age or younger; andWHEREAS, Juvenile idiopathic arthritis (JIA) is an autoinflammatory disease of an unknown origin and the most common type of arthritis in children; andWHEREAS, An autoinflammatory disease causes the immune system to become overactive even when there is no infection or illness to fight or mistakenly attack healthy cells and tissues; andWHEREAS, There is no evidence as to what causes JIA, and no links have been found that foods, toxins, allergies or the lack of vitamins play a role in developing the disease; andWHEREAS, Current research indicates that there is a genetic predisposition to JIA; andWHEREAS, Researchers believe that a trigger, such as a virus, 1234567891011121314151617 can initiate JIA in a child who has the genetic tendency; andWHEREAS, Systemic JIA, oligoarticular JIA, polyarticular JIA, juvenile psoriatic arthritis, enthesitis-related JIA and undifferentiated arthritis are the six subtypes of JIA; andWHEREAS, Nearly 300,000 children in the United States have some form of arthritis; andWHEREAS, Typical symptoms of arthritis include limping, stiffness when awakening, reluctance to use an arm or leg, reduced activity level, persistent fever, joint swelling and difficulty with fine motor skills; andWHEREAS, Most children with arthritis can expect to live normal lives and some even have their arthritis go into remission; andWHEREAS, There is a small number of specialists who treat JIA, and the Children's Hospital of Philadelphia is a leader in the field; andWHEREAS, According to the American College of Rheumatology, the best care for a child who has JIA is provided by a pediatric rheumatology team that has extensive experience and can diagnose and manage their complex needs; andWHEREAS, A pediatric rheumatology team may consist of a pediatric rheumatologist, a physical therapist, an occupational therapist, a social worker and a nurse specialist who coordinate care with other health professionals and school and community officials; andWHEREAS, The overall treatment goal for a child who has JIA is to control the symptoms, prevent joint damage and maintain function; andWHEREAS, Medications, including steroids, disease-modifying drugs and biologics along with physical and occupational therapy 20260HR0643PN3961 - 2 - 123456789101112131415161718192021222324252627282930 are used to treat JIA; andWHEREAS, Parents and caregivers of children who have JIA should be familiar with 29 U.S.C. Ch. 16 (relating to vocational rehabilitation and other rehabilitation services), which may provide for special accommodations at school; andWHEREAS, Children who have JIA may be eligible for assistance through services provided by State agencies; therefore be itRESOLVED, That the House of Representatives recognize the month of July 2026 as "Juvenile Arthritis Awareness Month" in Pennsylvania.20260HR0643PN3961 - 3 - 12345678910
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.